Signaling Pathways
-
A8328 LDK378Target: ALKSummary: Potent ALK inhibitor
-
A8329 R42810 CitationSummary: Selective Axl inhibitor
-
A8332 R788 disodiumTarget: SykSummary: Syk inhibitor,ATP competitive and potent
-
A8334 Linsitinib3 CitationSummary: IGF1R/IR inhibitor,potent and novel
-
A8350 AZD4547Target: FGFRSummary: FGFR inhibitor
-
A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2 inhibitor
-
A8347 Pazopanib HydrochlorideSummary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
-
A8357 AG-1478Target: EGFRSummary: EGFR inhibitor,potent and selective
-
A8361 AMG-458Summary: Potent c-Met inhibitor
-
A8365 Varlitinib (ARRY334543)Summary: ErbB inhibitor